Crowley Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Crowley Wealth Management's BIIB Position: Q4 2025 in Review
Crowley Wealth Management sold out of Biogen (BIIB) in Q4 2025, closing a stake of 4,810 shares — an estimated $674K sold.
Crowley Wealth Management first reported a position in BIIB in Q4 2024 and held it in 4 quarters. The position peaked at $944K in Q4 2024. 997 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.
- Crowley Wealth Management reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
- Crowley Wealth Management sold 4,810 Biogen shares in Q4 2025, an estimated $674K.
- Crowley Wealth Management first reported a position in Biogen in Q4 2024 and held it in 4 quarters.
- Crowley Wealth Management's Biogen position peaked at $944K in Q4 2024.
- 997 funds tracked by Wall St. Rank held Biogen as of Q4 2025.
Based on Crowley Wealth Management's 13F filing for Q4 2025.